Literature DB >> 3004745

Different localization of the product of the v-rel oncogene in chicken fibroblasts and spleen cells correlates with transformation by REV-T.

T D Gilmore, H M Temin.   

Abstract

Reticuloendotheliosis virus strain T (REV-T) is a highly oncogenic avian retrovirus that transforms early lymphoid cells in vivo and in vitro, but REV-T does not transform chicken embryo fibroblasts (CEF). Using antisera to p59v-rel, the v-rel oncogene product of REV-T, we show that p59v-rel is expressed at equal levels and is a phosphoprotein in REV-T infected spleen cells and CEF. Biochemical fractionation and immunofluorescence of REV-T infected nontransformed CEF show that p59v-rel is loosely associated with the nucleus. However, in REV-T transformed spleen cells p59v-rel is primarily a cytoplasmic protein. MSB-1 cells, a Marek's disease virus transformed T cell leukemic line, and E26 virus transformed myeloid cells show nuclear staining of p59v-rel when they are infected by REV-T. Our results indicate that there is a correlation between a cytoplasmic localization of p59v-rel and transformation by REV-T, and they suggest that p59v-rel cannot transform cells in which it assumes solely a nuclear location.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3004745     DOI: 10.1016/0092-8674(86)90845-7

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  55 in total

1.  The v-rel oncogene: insights into the mechanism of transcriptional activation, repression, and transformation.

Authors:  W H Walker; B Stein; P A Ganchi; J A Hoffman; P A Kaufman; D W Ballard; M Hannink; W C Greene
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  c-rel activates but v-rel suppresses transcription from kappa B sites.

Authors:  J Inoue; L D Kerr; L J Ransone; E Bengal; T Hunter; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

3.  Oncogenic transformation by vrel requires an amino-terminal activation domain.

Authors:  J Kamens; P Richardson; G Mosialos; R Brent; T Gilmore
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

4.  Both VP2 and VP3 are synthesized from each of the alternative spliced late 19S RNA species of simian virus 40.

Authors:  P J Good; R C Welch; A Barkan; M B Somasekhar; J E Mertz
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

5.  The RxxRxRxxC motif conserved in all Rel/kappa B proteins is essential for the DNA-binding activity and redox regulation of the v-Rel oncoprotein.

Authors:  S Kumar; A B Rabson; C Gélinas
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

6.  The C terminus of the NF-kappa B p50 precursor and an I kappa B isoform contain transcription activation domains.

Authors:  P J Morin; T D Gilmore
Journal:  Nucleic Acids Res       Date:  1992-05-25       Impact factor: 16.971

7.  Functional characterization of the NF-kappa B p65 transcriptional activator and an alternatively spliced derivative.

Authors:  S M Ruben; R Narayanan; J F Klement; C H Chen; C A Rosen
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

8.  A protein kinase-A recognition sequence is structurally linked to transformation by p59v-rel and cytoplasmic retention of p68c-rel.

Authors:  G Mosialos; P Hamer; A J Capobianco; R A Laursen; T D Gilmore
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

9.  vRel is an inactive member of the Rel family of transcriptional activating proteins.

Authors:  P M Richardson; T D Gilmore
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

10.  Loss of IkappaB alpha-mediated control over nuclear import and DNA binding enables oncogenic activation of c-Rel.

Authors:  S Sachdev; M Hannink
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.